VuCOMP Gets FDA Approval for Mammo CAD System

Article

Computer-aided detection system developer VuCOMP Inc. has received FDA premarket approval for its film mammography CAD software.

Computer-aided detection system developer VuCOMP Inc. has received FDA premarket approval for its film mammography CAD software. This is the first new mammography CAD system approved by the FDA since 2007, the company said.

M-Vu is indicated for use in screening mammography to identify areas consistent with breast cancer for radiologist review after completing an initial read, according to the company.

In a reader study at the University of North Carolina at Chapel Hill, physicians using the M-Vu CAD system were more effective at reading mammograms and demonstrated a significant increase in the ability to discriminate between cancer and noncancer, according to VuCOMP.

The company will be providing a digital version of the system in the “near future,” VuCOMP president and CEO Jeff Wehnes said in a statement.

 

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.